NARA Discovery
Article Details
← Back to Search Results
Journal Article

The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer

D. A. De La Cruz-Sigüenza; J. P. Reyes-Grajeda; M. A. Velasco-Velázquez; C. Trejo-Becerril; E. Pérez-Cárdenas; A. Chávez-Blanco; L. Taja-Chayeb; G. Domínguez-Gómez; M. P. Ramos-Godinez; A. González-Fierro; A. Dueñas-González
Molecular Biology Reports · Vol. 51, Issue 1 · 2024

Abstract

Background Cell-free DNA (cfDNA) is a source for liquid biopsy used for cancer diagnosis, therapy selection, and disease monitoring due to its non-invasive nature and ease of extraction. However, cfDNA also participates in cancer development and progression by horizontal transfer. In humans, cfDNA circulates complexed with extracellular vesicles (EV) and macromolecular complexes such as nucleosomes, lipids, and serum proteins. The present study aimed to demonstrate whether cfDNA not associated with EV induces cell transformation and tumorigenesis. Methods Supernatant of the SW480 human colon cancer cell line was processed by ultracentrifugation to obtain a soluble fraction (SF) and a fraction associated with EV (EVF). Primary murine embryonic fibroblast cells (NIH3T3) underwent passive transfection with these fractions, and cell proliferation, cell cycle, apoptosis, cell transformation, and tumorigenic assays were performed. Next, cfDNA was analyzed by electronic microscopy, and horizontal transfer was assessed by human mutant KRAS in recipient cells via PCR and recipient cell internalization via fluorescence microscopy. Results The results showed that the SF but not the EVF of cfDNA induced proliferative and antiapoptotic effects, cell transformation, and tumorigenesis in nude mice, which were reduced by digestion with DNAse I and proteinase K. These effects were associated with horizontal DNA transfer and cfDNA internalization into recipient cells. Conclusions The results suggest pro-tumorigenic effects of cfDNA in the SF that can be offset by enzyme treatment. Further exploration of the horizontal tumor progression phenomenon mediated by cfDNA is needed to determine whether its manipulation may play a role in cancer therapy.

Bibliographic Information

JournalMolecular Biology Reports
PublisherSpringer
Publication Date2024-12-01
Publication Year2024
Volume51
Issue1
Document TypeJournal Article
Print ISSN0301-4851
eISSN1573-4978
DOI10.1007/s11033-023-09016-w

Access Information

NARA Access Coverage1973-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11033
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.